NCT07254585: SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 110 planned
- Started
- 12 Dec 2025
- Primary completion
- 30 Jun 2028
- Arms
- Enlonstobart group
- Results
- None posted
- 28 Nov 2025: Trial registered
- 12 Dec 2025: Trial started